Elinzanetant Shows Promise in Managing Vasomotor Symptoms for Menopausal and Breast Cancer Patients
Discover how Bayer's elinzanetant offers promising relief for vasomotor symptoms in menopausal and breast cancer patients, with significant trial results showing reduced hot flashes and improved sleep.
FDA Issues GBS Warning for GSK and Pfizer RSV Vaccines
The FDA's issues a new warning on GSK and Pfizer's RSV vaccines regarding a potential risk of Guillain-Barré syndrome.
FDA Announces Center for Real-World Evidence Innovation (CCRI)
FDA announced the Center for Drug Evaluation and Research (CDER) has launched the Center for Real-World Evidence Innovation (CCRI) in hopes of enhancing the integration of real-world evidence into regulatory decision-making.
The Transformative Role of AI in Clinical Trials and Drug Development
Discover how AI is revolutionizing clinical trials and drug development, enhancing efficiency, accuracy, and patient care, while facing adoption challenges in the biopharma industry.
Facilitating Value-Based Agreements with Commercial US Payers using RWE
Explore how real-world evidence (RWE) is shaping value-based care in the US healthcare system. Learn how RWE supports regulatory decisions, insurance coverage, and cost-effective treatment strategies to improve patient outcomes and reduce healthcare spending.
Impact of Shift Changes on Triage Accuracy and Patient Care in Emergency Departments
A study of over 2 million emergency department records reveals that triage nurses become more lenient during their shifts, leading to lower priority assignments for patients arriving just after shift changes. This results in reduced care levels and increased need for further emergency treatment.
Segmed and Bayer Collaborate to Transform Healthcare Innovation with RWiD Solution
Segmed, a leading provider of real-world imaging data, has announced a partnership with Bayer to integrate its data platform into Bayer's healthcare ecosystem.
Market Access “Back to School”: How to Plan and Prioritize Your 2025 Projects
Plan for 2025 in biopharma with insights on adapting to market changes, leveraging digital tools, and engaging key opinion leaders. Ensure guideline inclusion and stay competitive with strategic positioning. Use this checklist to prioritize initiatives for the evolving landscape.
Advancing Precision in Long COVID Research Through Enhanced Phenotyping
Discover how a novel precision phenotyping algorithm improves the identification of long COVID patients, enhancing research accuracy and reducing demographic biases in cohort studies.
Decoding the Role of E. coli in Colon Cancer Development
New research reveals how specific E. coli bacteria contribute to colon cancer by binding to intestinal cells and releasing a DNA-damaging toxin. Discover potential therapeutic approaches to mitigate cancer risk without disrupting beneficial gut microbes.
Veradigm Enhances Patient Outcomes Through Integrated Care Gap Management
Discover how integrated care gap management solutions, like Veradigm Payer Insights, improve patient outcomes by seamlessly delivering care alerts within EHRs, reducing provider workload, and promoting timely interventions for enhanced healthcare experiences.
Study Reveals Significant Survival Benefits for Asymptomatic Aortic Stenosis Patients Undergoing Early Valve Replacement
egnite Inc., a leader in cardiovascular digital health, presented groundbreaking research at the Transcatheter Cardiovascular Therapeutics [...]
“S” Stands for Systematic: Demystifying the Systematic Literature Review
In this webinar, experts present an overview of systematic literature reviews, detailing their purpose, execution, decision-making criteria, and suitability for addressing key questions in the pharmaceutical industry.
RSV Vaccine Proves Effective in Preventing Severe Illness in Older Adults, Study Finds
A study published in The Lancet by the VISION Network shows the RSV vaccine is about 80% [...]
Veradigm Enhances EHR Insights with NLP Integration
Veradigm has fully integrated advanced natural language processing (NLP) into its electronic health record (EHR) dataset, [...]
Flatiron Health and Lifebit Extend Partnership to Advance Cancer Research in Japan Using Secure Real-World Data
Flatiron Health and Lifebit have expanded their partnership to Japan with the goal of enhancing cancer [...]
Real-World Study Validates Pemigatinib’s Efficacy in Diverse Cholangiocarcinoma Patients
A real-world study published in The Oncologist confirms the clinical benefits of the FGFR inhibitor pemigatinib [...]
Accelerating Development of Rare Genetic Disease Therapeutics
Healthcare equity is a complex problem. It requires dedicated solutions. By working with the right data partner, researchers can gather real-world data aimed at better understanding patient healthcare journeys. HEOR studies can yield new insights into disparities, presenting opportunities to create a more equitable healthcare system in which patient economic factors and geography don’t limit access to care.
Treatment Dynamics in ADHD Patients with Comorbidities: A Real World Analysis
This study by Liman, C. et al. (2024) examined how psychiatric comorbidities and patient characteristics affect treatment [...]
FDA’s Real-World Data Guidance: A Game Changer for Eye Care Innovation and Patient Outcomes
The FDA's final guidance on real-world data (RWD) integration for regulatory decision-making marks a significant advancement [...]
Emulating Clinical Trials with Real-World Data: Insights from Powell et al.’s Study on Anticoagulants in Atrial Fibrillation
Powell and colleagues conducted a study to emulate the ARISTOTLE trial using real-world data to assess [...]
Advancing Health Equity by Leveraging Social Determinants of Health Data
Healthcare equity is a complex problem. It requires dedicated solutions. By working with the right data partner, researchers can gather real-world data aimed at better understanding patient healthcare journeys. HEOR studies can yield new insights into disparities, presenting opportunities to create a more equitable healthcare system in which patient economic factors and geography don’t limit access to care.
Improving Precision Medicine through Real-World Evidence Platforms
In precision medicine, leveraging real-world data to generate actionable real-world evidence (RWE) is crucial for developing [...]
Automated Detection of Sleep Positions in Pregnant Women Using Deep Learning
A recent study links sleeping on the back after 28 weeks of pregnancy with risks such [...]
AstraZeneca and Tempus Collaborate to Improve Oncology R&D with AI and Real-World Data
AstraZeneca and Tempus recently announced a collaboration to tackle rising pharmaceutical R&D costs, with a focus [...]
